I 40 CYS 28 -16.885 -18.163
I 41 ARG 6 -16.572 -15.356
I 42 LEU 29 -17.078 -18.449
I 43 ASP 1 -13.673 -12.216
I 44 LYS 0 -11.869 -10.504
I 45 SER 6 -10.317 -9.820
I 46 ASN 23 -14.027 -15.059
I 58 MET 2 -7.683 -7.029
I 59 LEU 14 -8.386 -9.031
I 60 ALA 2 -9.755 -8.863
I 61 LYS 6 -9.425 -9.031
I 62 GLU 3 -5.120 -4.876
I 63 ALA 17 -9.226 -10.120
I 64 TRP 7 -5.656 -5.810
I 65 ASN 4 -3.405 -3.474 <=B
I 66 TRP 9 -5.026 -5.483
I 67 ASP 20 -6.829 -8.344
I 68 ASP 3 -4.812 -4.603
I 69 ILE 7 -5.805 -5.943
I 70 THR 0 -4.706 -4.164
I 71 ASP 13 -5.277 -6.166
I 72 VAL 11 -6.838 -7.317
I 73 ARG 22 -10.829 -12.114
I 74 LEU 33 -13.977 -16.165
I 75 ILE 28 -16.493 -17.816
I 76 GLY 15 -14.346 -14.421
I 77 GLU 2 -11.730 -10.611
I 78 LYS 9 -8.881 -8.895
I 79 LEU 28 -14.651 -16.186
I 80 PHE 18 -13.792 -14.276
I 81 HIS 11 -8.589 -8.866
I 82 GLY 12 -7.792 -8.276
I 83 VAL 28 -11.927 -13.775
I 84 SER 10 -10.596 -10.527
I 85 MET 1 -11.282 -10.100
I 86 SER 5 -12.115 -11.296
I 87 GLU 18 -13.985 -14.447
I 88 ARG 20 -17.602 -17.878
I 89 CYS 22 -19.582 -19.860
I 90 TYR 21 -18.228 -18.547
I 91 LEU 29 -17.489 -18.813
I 92 MET 30 -20.377 -21.484
I 93 LYS 23 -19.377 -19.794
I 94 GLN 22 -17.471 -17.992
I 95 VAL 38 -19.391 -21.531
I 96 LEU 32 -20.500 -21.823
I 97 ASN 17 -16.843 -16.861
I 98 PHE 29 -15.919 -17.423
I 99 THR 36 -18.014 -20.082
I 100 LEU 18 -17.262 -17.347
I 101 GLU 11 -13.807 -13.485
I 102 GLU 16 -11.764 -12.251
I 119 VAL 6 -16.017 -14.865
I 120 PRO 0 -14.506 -12.838
I 121 PHE 12 -16.781 -16.231
I 122 LEU 18 -19.367 -19.209
I 123 ALA 5 -17.870 -16.390
I 124 ARG 9 -15.609 -14.849
I 125 LEU 34 -19.723 -21.365
I 126 SER 16 -19.098 -18.742
I 127 ASN 7 -14.856 -13.953
I 128 ARG 19 -15.534 -15.933
I 129 LEU 31 -17.989 -19.485
I 130 SER 4 -14.979 -13.716
I 131 THR 5 -12.850 -11.947
I 132 CYS 28 -16.208 -17.564
I 133 HIS 6 -12.922 -12.126
I 134 ILE 20 -11.424 -12.410
I 135 GLU 0 -7.654 -6.774
I 136 GLY 6 -5.509 -5.566
I 137 ASP 4 -5.171 -5.037
I 138 ASP 19 -8.652 -9.842
I 139 LEU 1 -6.704 -6.048
I 140 HIS 14 -7.189 -7.972
I 141 ILE 22 -12.231 -13.354
I 142 GLN 7 -11.284 -10.792
I 143 ARG 7 -7.830 -7.734
I 144 ASN 24 -11.571 -13.000
I 145 VAL 24 -14.352 -15.462
I 146 GLN 6 -10.335 -9.836
I 147 LYS 19 -8.345 -9.571
I 148 LEU 35 -13.801 -16.239
I 149 LYS 18 -11.101 -11.894
I 150 ASP 7 -5.991 -6.107
I 151 THR 19 -7.656 -8.960
I 152 VAL 28 -10.314 -12.348
I 153 LYS 11 -5.815 -6.411
I 154 LYS 7 -3.539 -3.937
I 155 LEU 17 -4.752 -6.160
I 156 GLY 1 -3.907 -3.573 <=B
I 157 GLU 0 -6.051 -5.355
I 158 SER 7 -6.247 -6.334
I 159 GLY 15 -8.271 -9.045
I 160 GLU 4 -9.880 -9.204
I 161 ILE 5 -10.433 -9.808
I 162 LYS 20 -10.527 -11.616
I 163 ALA 25 -14.004 -15.268
I 164 ILE 10 -13.834 -13.393
I 165 GLY 22 -13.404 -14.393
I 166 GLU 26 -15.337 -16.564
I 167 LEU 17 -18.388 -18.229
I 168 ASP 11 -18.029 -17.221
I 169 LEU 22 -18.252 -18.683
I 170 LEU 26 -20.684 -21.295
I 171 PHE 19 -20.519 -20.344
I 172 MET 15 -18.668 -18.246
I 173 SER 26 -19.541 -20.283
I 174 LEU 29 -21.323 -22.206
I 175 ARG 10 -19.252 -18.188
I 176 ASN 11 -17.518 -16.769
I 177 ALA 31 -18.949 -20.335
I 178 CYS 33 -18.778 -20.414
I 179 ILE 9 -15.754 -14.977

Identified 2 B-Cell epitope residues out of 113 total residues